These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36674962)

  • 21. Species distribution and antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from pediatric ICU patients in Tehran, Iran.
    Mirhendi H; Charsizadeh A; Eshaghi H; Nikmanesh B; Arendrup MC
    Med Mycol; 2020 Feb; 58(2):201-206. PubMed ID: 31111910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom.
    Borman AM; Muller J; Walsh-Quantick J; Szekely A; Patterson Z; Palmer MD; Fraser M; Johnson EM
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
    Minea B; Nastasa V; Moraru RF; Kolecka A; Flonta MM; Marincu I; Man A; Toma F; Lupse M; Doroftei B; Marangoci N; Pinteala M; Boekhout T; Mares M
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):367-83. PubMed ID: 25224578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.
    Morace G; Borghi E; Iatta R; Amato G; Andreoni S; Brigante G; Farina C; Lo Cascio G; Lombardi G; Manso E; Mussap M; Pecile P; Rigoli R; Tangorra E; Valmarin M; Montagna MT
    BMC Infect Dis; 2011 May; 11():130. PubMed ID: 21586108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
    Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
    Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E; Hammarström H; Ataollahy N; Kondori N
    Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal susceptibility profile of yeasts isolated from the oral cavity of cats.
    Nikaein D; Shirani D; Sharifzadeh A; Alavi A; Khosravi AR
    Vet Med Sci; 2023 Nov; 9(6):2414-2419. PubMed ID: 37847594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and Antifungal Susceptibility of
    Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
    Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular identification, antifungal susceptibility, and resistance mechanisms of pathogenic yeasts from the China antifungal resistance surveillance trial (CARST-fungi) study.
    Wang Q; Cai X; Li Y; Zhao J; Liu Z; Jiang Y; Meng L; Li Y; Pan S; Ai X; Zhang F; Li R; Zheng B; Wan Z; Liu W
    Front Microbiol; 2022; 13():1006375. PubMed ID: 36274705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of
    Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L
    Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China.
    Hong N; Lei Y; Chen H; Chen X; Tsui KM; Hu D; Liao W; Yan L; Zhang H; Zhao R; Wu G; Yu N; Deng S
    Mycopathologia; 2022 Jun; 187(2-3):217-224. PubMed ID: 35072854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.